Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Pure Bioscience Inc's Competitiveness

Name: Pure Bioscience Inc Competitors and Peer Comparison
Creator: CSIMarket
License: https://csimarket.com/help/terms-of-use

A competitive positioning analysis and financial ratio benchmarking of Pure Bioscience Inc (PURE) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q4 2026

Competitors

Named by the company

Peer Group Market Share

100.00 %

vs 100.00 % a year ago

Revenue Growth Y/Y

-13.74 %

Q4 2026

Net Margin

-92.56 %

Q4 2026

Key Findings: Pure Bioscience Inc vs Its Competitors

TTM: Trailing 12-month revenue of 2M vs -M combined for its competitors (100.0% combined share).
Trending: Latest-quarter revenue run-rate is accelerating (+13.8% annualized vs trailing 12 months).
Scale: Pure Bioscience Inc ranks #73 of 81 companies by market capitalization in the Chemical Manufacturing industry, holding 0.0% of industry market cap.
Peer revenue share: Pure Bioscience Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

PURE Sales vs. its Competitors, Q4 2026

Pure Bioscience Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/PURE/competitors

https://api.csimarket.com/api/v1/companies/PURE/relationships

https://api.csimarket.com/api/v1/companies/PURE/similar

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Business Relationships API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AI Integration via MCP

Connect Claude, ChatGPT, or any MCP-compatible AI assistant directly to this data.

For context: the Chemical Manufacturing industry grew revenue 1.9% year over year, combined, vs -13.7% for Pure Bioscience Inc. Pure Bioscience Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.

Pure Bioscience Inc's Competitor Quality Breadth

Group definitions: see Methodology: Performance Group Definitions.

Entity	Profitable	Expanding	Above Industry Growth	Distressed
Pure Bioscience Inc	-	Yes	Yes	No
Similar-Size Competitors (10)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

PURE Stock Performance relative to its Competitors

PURE Competitors (weighted) Percent change over the selected range

Pure Bioscience Inc's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.

Similar-Size
(2 of 7)

Entity	TTM Share Price Return (group: median)	vs U.S.A. 500
Pure Bioscience Inc	-	-
Competitors combined (0)	40.4%	63.2%
High-Confidence Competitors (0)	40.4%	63.2%
Similar-Size Competitors (7)	40.4%	63.2%
Similar Growth & Profitability (0)	40.4%	63.2%

Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Pure Bioscience Inc's competitor groups requires a Commercial License.

Unlock Full Access

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

PURE Stock Performance relative to Similar-Size Competitors

PURE Similar-Size Competitors (equal-weighted, 10) Percent change over the selected range

Pure Bioscience Inc's Comment on Competition and Industry Peers

The company operates in the antimicrobial technology market, competing with established products and industry leaders. Although SDC-based products offer benefits such as being non-toxic and non-caustic, they require significant investment to replace traditional technologies and tend to have higher production costs, which may affect customer adoption.